Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Improved Havrix approved by FDA

April 12, 1996

OraVax granted patent on H. pylori vaccine technology

April 12, 1996

Provir to enter phase II soon

April 5, 1996

Lexipafant for pancreatitis

March 15, 1996

Zadaxin effective in HBV patients

March 15, 1996

Calixarene derivatives from University of Alabama

March 15, 1996

Dosmalfate pending Spanish approval

March 15, 1996

Teikoku Hormone claims antiulcer drugs

March 15, 1996

Takeda targets Helicobacter pylori

March 15, 1996

Anti-Helicobacter agents from Janssen

March 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...